Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Prostatic Neoplasms: HELP
Yohann Loriot
Based on 46 articles published since 2008
||||
Expertise Level
The expertise of Yohann Loriot ranks in the
  • Top 0.22%
  • ... of 138,005 published authors worldwide on Prostatic Neoplasms
  • ... from 2008 through 2019
  • ... based on contributions to 46 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Loriot, Yohan   ·   Loriot, Yohann   ·   Loriot, Y
Work Locations
Details
Most likely:    Institut Gustave Roussy      
2018
  • Gustave-Roussy, département de médecine, Inserm U981, 114, rue Édouard-Vaillant, 94805 Villejuif, France. · CHU de Besançon, oncologie, 25030 Besançon cedex, France. · CHU de Besançon, oncologie, 25030 Besançon cedex, France; Inserm, UMR1098, 25020 Besançon cedex, France; Université de Franche-Comté, UMR1098, SFR IBCT, 25020 Besançon, France. Electronic address: · Pubmed 30278883
  • Department of Medical Cell BioPhysics, University of Twente, Enschede, The Netherlands. · Department of General, Visceral and Pediatric Surgery, University Hospital of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. · Department of Gynecology and Obstetrics, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. · Institute for Transplantation Diagnostics and Cell Therapeutics, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. · Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · DiSCOG, University of Padova, Padova, Italy. · Apheresis Unit, Blood Transfusion Service, University Hospital of Padova, Padova, Italy. · Department of Medicine, Université Paris-Saclay, Gustave Roussy, Villejuif, France. · INSERM U981 "Identification of Molecular Predictors and New Targets for Cancer Treatment", Gustave Roussy, Villejuif, France. · "Circulating Tumor Cells" Translational Platform, CNRS UMS3655 - INSERM US23 Ammica, Université Paris-Saclay, Gustave Roussy, Villejuif, France. · Cancer Biomarkers, Institute of Cancer Research, Sutton, UK. · Prostate Cancer Targeted Therapies Group, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Pubmed 30006930
2017
  • Office of Health Economics, Southside, 7th Floor, 105 Victoria Street, London, SW1E 6QT, UK. · Office of Health Economics, Southside, 7th Floor, 105 Victoria Street, London, SW1E 6QT, UK. · European Association for the Study of the Liver-Chronic Liver Failure (EASL-CLIF) Consortium, C/Mallorca 183, 08036, Barcelona, Spain. · Astellas Pharma Global Development, J.H. Oortweg 62, 2333 BE, Leiden, The Netherlands. · Astellas Medical Affairs, Global Health Economic Outcomes Research (HEOR), 2000 Hillswood Dr, Chertsey, Surrey, KT16 0PS, UK. · OHSU Knight Cancer Institute, Oregon Health & Science University, 3303 SW Bond Ave., CH14R, Portland, OR, 97239, USA. · Institut de Recherche Clinique (IREC), Cliniques Universitaires Saint Luc, Av Hippocrate, 10 - 1200 Bruxelles - Belgique, Brussels, Belgium. · Institut Gustave Roussy, University of Paris Sud, 114, rue Edouard-Vaillant, 94805, Villejuif Cedex, France. · Quintiles, Siriusdreef 10 Beukenhorst Zuid 2132, WT, Hoofddorp, The Netherlands. · Medivation, Inc., 525 Market St, Fl 36, San Francisco, CA, 94105, USA. · Astellas Medical Affairs, Global HEOR, J.H. Oortweg 62, 2333 BE, Leiden, The Netherlands. · Pubmed 28645287
  • OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR. Electronic address: · Department of Medical Oncology, Guy's Hospital, London, UK. · Department of Cancer Medicine, Gustave Roussy, University of Paris-Sud, Villejuif, France. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Division of Clinical Studies, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Department of Urology, Cliniques universitaires Saint-Luc, Brussels, Belgium. · Department of Medical Oncology, Vall d'Hebron University Hospital, and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Medicine, University of Colorado School of Medicine, Aurora, CO. · Department of Medical Oncology, USC Norris Cancer Hospital, Keck Medical Center of USC, Los Angeles, CA. · Department of Biostatistics, Astellas Pharma Europe, BV, Leiden, Netherlands. · Department of Biostatistics, Medivation, Inc, San Francisco, CA. · Department of Clinical Development, Medivation, Inc, San Francisco, CA. · OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR. · Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA. · Pubmed 28344102
  • Department of Drug Development, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA. · Comprehensive Cancer Center Yale School of Medicine, New Haven. · Sanofi Genzyme, Cambridge, USA. · Pubmed 28039155
  • Department of Cancer Medicine, Gustave Roussy, Département de Médecine Oncologique, Université Paris-Saclay, Villejuif, France. · The Royal Marsden National Health Service Foundation Trust and The Institute of Cancer Research, Sutton, United Kingdom. · Medivation, Inc, San Francisco, California. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Pubmed 27648814
  • Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. Electronic address: · Duke Cancer Institute, Durham, NC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave-Roussy, Villejuif, France. · San Camillo and Forlanini Hospitals, Rome, Italy. · University of Washington, Seattle Cancer Care Alliance, Seattle, WA, USA. · Rigshospitalet, Copenhagen, Denmark. · UC Davis Cancer Center, Sacramento, CA, USA. · Asan Medical Center, Seoul, Korea. · Nippon Medical School, Tokyo, Japan. · Charité Universitätsmedizin, Berlin, Germany. · University of Montreal Hospital Center, Montreal, QC, Canada. · Skåne University Hospital, Malmö, Sweden. · Aarhus University Hospital, Aarhus, Denmark. · Radboud University Medical Center, Nijmegen, Netherlands. · Tampere University Hospital and University of Tampere, Tampere, Finland. · Medivation, San Francisco, CA, USA. · Astellas Pharma Europe, Leiden, The Netherlands. · Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27477525
  • Institut Gustave Roussy, University of Paris-Sud, Department of Cancer Medicine, 114 Rue Edouard Vaillant, 94800 Villejuif, France. · Institut Paoli-Calmettes, Department of Medical Oncology, 13009 Marseille, France. · Pubmed 28428880
  • Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA. · OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Department of Clinical Medicine, Rigshospitalet, Copenhagen, Denmark. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Cancer Medicine, Institut Gustave-Roussy, Villejuif, France. · Division of Clinical Studies, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Division of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Medical Affairs, Medivation, Inc., San Francisco, CA, USA. · Biostatistics, Medivation, Inc., San Francisco, CA, USA. · Medical Oncology, Astellas Pharma, Inc., Northbrook, IL, USA. · Biostatistics, Astellas Pharma, Inc., Northbrook, IL, USA. · Pubmed 28117385
  • Prostate Cancer Research, Montreal Cancer Institute/CRCHUM, Centre de Hospitalier de Université de Montréal, Montréal, QC, Canada. · Quintiles, Hoofddorp, The Netherlands. · Astellas Pharma, Leiden, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Medivation, San Francisco, CA, USA. · OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. · Cliniques universitaires Saint-Luc, Bruxelles, Belgium. · Astellas Medical Affairs, Global HEOR, Leiden, The Netherlands. · Pubmed 28045115
2016
  • Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Pubmed 27151554
  • Department of Urology, UC Davis Comprehensive Cancer Center, Sacramento, CA, USA. Electronic address: · Medical Oncology Division, University of Washington/Seattle Cancer Care Alliance, Seattle, WA, USA. · Department of Urology, Medical University of South Carolina, Charleston, SC, USA. · Division of Urologic Surgery, Washington University School of Medicine, St. Louis, MO, USA. · Department of Surgery, University of Montreal Health Center, Montreal, Canada. · Copenhagen Prostate Cancer Center, Rigshospitalet, University of Copenhagen, Denmark. · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Urology, Asan Medical Center, Seoul, South Korea. · Department of Urology, Nippon Medical School Hospital, Tokyo, Japan. · Division of Medical Oncology and Urology, Duke Cancer Institute, Durham, NC, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave-Roussy, Villejuif, France. · Drug Development Unit, Institute of Cancer Research, Royal Marsden Hospital, London, UK. · Department of Early Clinical Development, Medivation, Inc., San Francisco, CA, USA. · Department of Medical Affairs, Medivation, Inc., San Francisco, CA, USA. · Department of Biostatistics, Medivation, Inc., San Francisco, CA, USA. · Astellas Pharma, Inc., Northbrook, IL, USA. · Department of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27006332
  • Gustave Roussy, Université Paris-Saclay, Department of Medicine, F-94805, Villejuif, France. · INSERM, U981 "Identification of Molecular Predictors and New Targets for Cancer Treatment", F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Circulating Tumor Cells" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Hôpital d'Instruction des Armées du Val de Grâce, Department of Oncology, F-75005, Paris, France. · Gustave Roussy, Université Paris-Saclay, Department of Biopathology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, Department of Biostatistics and Epidemiology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Histo Cytopathology" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Pubmed 27391263
  • The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France INSERM U981, Villejuif, France. · The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada · Pubmed 27198502
  • INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Bergonie Cancer Institute, Bordeaux, France. · INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Biopathology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. · Pubmed 26923772
  • Department of Medical Oncology, Institut Bergonié, Bordeaux. · Department of Medical Oncology, Clinique Francheville, Périgueux. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif. · Department of Radiotherapy, Institut Bergonié, Bordeaux, France. · Department of Medical Oncology, Institut Bergonié, Bordeaux · Pubmed 26445811
2015
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Pubmed 25922192
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Drug Development Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Department of Urology, Guys and St Thomas' Hospital, London, UK. · Department of Medicine, Division of Medical Oncology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Early Clinical Development, Medivation, San Francisco, CA, USA. · Health Economics and Outcomes Research, Astellas Pharma Europe, Leiden, Netherlands. · Department of Medical Affairs, Medivation, San Francisco, CA, USA. · Astellas Pharma Global Development, Northbrook, IL, USA. · Consulting, Quintiles, Hoofddorp, Netherlands. · Consulting, Quintiles, Barcelona, Spain; Department of Public Health, University of Barcelona, Barcelona, Spain. · Division of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 25888263
  • University of Montreal Hospital Centre, Montreal, QC, Canada. Electronic address: · Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Gustave Roussy, Cancer Campus Grand Paris, University of Paris Sud, Villejuif, France. · Medivation, Inc., San Francisco, CA, USA. · Astellas Global Medical Affairs, Inc., Northbrook, IL, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 25171902
  • Department of Ambulatory Care, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. Electronic address: · Department of Biostatistics and Epidemiology, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Gustave-Roussy Cancer Campus, Villejuif, University of Paris Sud, France. · Department of Ambulatory Care, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Pubmed 26278649
  • Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Institut Jean Godinot, Reims, France. · Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Pubmed 26208462
  • Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Urology, University Hospital of Pointe-à-Pitre, France. · Department of Urology, Kremlin-Bicêtre Hospital, University of Paris-Sud, Kremlin-Bicêtre, France. · Department of Urology, Saint-Joseph Hospital, Paris, France. · Department of Radiotherapy, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Forestry and Management of the Environment and Natural Resources, School of Agricultural Sciences and Forestry, Democritus University, Alexandroupoli, Greece. · Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Pubmed 25746940
  • Department of Medicine, University of Washington, Seattle, WA, USA. Electronic address: · Janssen Research and Development, Los Angeles, CA, USA. · Janssen Research and Development, Menlo Park, CA, USA. · Janssen Research and Development, Raritan, NJ, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Institut Gustave Roussy, Villejuif, France. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, UK. · Pubmed 25018037
  • Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, Val de Grâce Hospital, Paris, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, CHU de Bordeaux, Bordeaux, France. · Pitié-Salpetrière Hospital, Paris, France. · Institut de Cancérologie de la Loire, Saint-Etienne, France. · Biostatistics and Epidemiology unit, Institut Gustave Roussy, Cancer Campus, Grand Paris, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Pubmed 24837187
2014
  • Department of Cancer Medicine, Institut Gustave Roussy and University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Institut Gustave Roussy and University of Paris Sud, Villejuif, France; Drug Development Department, SITEP, Institut Gustave Roussy, Villejuif, France. Electronic address: · Pubmed 24735730
  • Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris Sud, Villejuif, France. · Pubmed 24075577
  • Institut Gustave-Roussy, DITEP, Département d'innovations thérapeutiques et essais précoces, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. · Institut Gustave-Roussy, Département de médecine oncologique, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. · Service d'oncologie et hématologie, 4, rue Louis-Pasteur, 28630 Chartres Le Coudray, France. · Pubmed 24793632
  • Institute Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Villejuif, France, · Pubmed 24771350
  • Department of Cancer Medicine, Gustave Roussy, Villejuif, France. · Institut Jean-Godinot, Reims, France. · Pubmed 25311767
2013
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Sud, INSERM 981, Villejuif, France. · Pubmed 23576708
2012
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 22267211
2010
  • Department of Medicine, Institut Gustave Roussy, Villejuif, France. · Pubmed 20483588
2015
  • a Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, 114 rue Edouard Vaillant, 94800 Villejuif, France. · Pubmed 26313416
2012
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif 94800, France. · Pubmed 22987974
2010
  • Department of Medicine, Institut Gustave Roussy, University of Paris XI, Villejuif, France. · Pubmed 20181574
  • Institut Gustave-Roussy, Département de Médecine, 39 Rue Camille-Desmoulins, 94800 Villejuif, France. · Pubmed 20022854
2009
  • Department of Medicine, Institut Gustave Roussy, Villejuif, France. · Pubmed 19364971
Probable:    INSERM France      
2018
  • Gustave-Roussy, département de médecine, Inserm U981, 114, rue Édouard-Vaillant, 94805 Villejuif, France. · CHU de Besançon, oncologie, 25030 Besançon cedex, France. · CHU de Besançon, oncologie, 25030 Besançon cedex, France; Inserm, UMR1098, 25020 Besançon cedex, France; Université de Franche-Comté, UMR1098, SFR IBCT, 25020 Besançon, France. Electronic address: · Pubmed 30278883
  • Department of Medical Cell BioPhysics, University of Twente, Enschede, The Netherlands. · Department of General, Visceral and Pediatric Surgery, University Hospital of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. · Department of Gynecology and Obstetrics, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. · Institute for Transplantation Diagnostics and Cell Therapeutics, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. · Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · DiSCOG, University of Padova, Padova, Italy. · Apheresis Unit, Blood Transfusion Service, University Hospital of Padova, Padova, Italy. · Department of Medicine, Université Paris-Saclay, Gustave Roussy, Villejuif, France. · INSERM U981 "Identification of Molecular Predictors and New Targets for Cancer Treatment", Gustave Roussy, Villejuif, France. · "Circulating Tumor Cells" Translational Platform, CNRS UMS3655 - INSERM US23 Ammica, Université Paris-Saclay, Gustave Roussy, Villejuif, France. · Cancer Biomarkers, Institute of Cancer Research, Sutton, UK. · Prostate Cancer Targeted Therapies Group, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Pubmed 30006930
2016
  • Gustave Roussy, Université Paris-Saclay, Department of Medicine, F-94805, Villejuif, France. · INSERM, U981 "Identification of Molecular Predictors and New Targets for Cancer Treatment", F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Circulating Tumor Cells" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Hôpital d'Instruction des Armées du Val de Grâce, Department of Oncology, F-75005, Paris, France. · Gustave Roussy, Université Paris-Saclay, Department of Biopathology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, Department of Biostatistics and Epidemiology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Histo Cytopathology" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Pubmed 27391263
  • The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France INSERM U981, Villejuif, France. · The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada · Pubmed 27198502
2015
  • Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, Val de Grâce Hospital, Paris, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, CHU de Bordeaux, Bordeaux, France. · Pitié-Salpetrière Hospital, Paris, France. · Institut de Cancérologie de la Loire, Saint-Etienne, France. · Biostatistics and Epidemiology unit, Institut Gustave Roussy, Cancer Campus, Grand Paris, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Pubmed 24837187
2013
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Sud, INSERM 981, Villejuif, France. · Pubmed 23576708
Probable:    Universite Paris-Saclay      
2018
  • Medical Oncology Department, Gustave Roussy, Université Paris-Saclay, Paris, France. Electronic address: · Radiation Therapy Department, Institut de Cancérologie de L'Ouest René Gauducheau, Nantes St Herblain and Centre de Recherche en Cancérologie et Immunologie, Nantes-Angers, France. · Department of Urology, CHU Rangueil, Toulouse, France. · Medical Oncology Department, CHIC Quimper, France; CHRU Brest, Institut de Cancérologie et Hématologie, Brest, France. · Groupe Urologie Bordeaux Saint Gatien- Clinique TIVOLI-DUCOS, GROUPE SAINT GATIEN, Bordeaux, France. · Department of Radiation Therapy, Institut Bergonié, Bordeaux, France. · Medical Oncology and Hematology Department, Hôpitaux Universitaires de Strasbourg, Strasbourg, France. · Service de Chirurgie Oncologique 2, Institut Paoli-Calmettes, Marseille, France. · Medical Oncology Department, Centre Hospitalier Lyon-Sud, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), CITOHL, F-69310 Pierre-Bénite, France. · Department of Urology, Rennes University Hospital, Rennes, France. · Ramsay Générale de Santé, Hôpital Privé Clairval, Marseille, France. · Department of Urology, Clinique La Croix du Sud-St Jean Languedoc, Toulouse, France, Institut Universitaire du Cancer, Toulouse, France. · Department of Urology, Hôpital européen Georges-Pompidou (HEGP), Assistance Publique-Hôpitaux de Paris (APHP), Paris, France; Paris-Descartes University, Paris, France. · Department of Oncology, Antoine-Lacassagne Center, Nice, France. · Pubmed 30300771
  • Department of Urology, CHU Rangueil, Toulouse, France. Electronic address: · Medical oncology department, Gustave Roussy, Université Paris-Saclay, Paris, France. Electronic address: · Department of Radiation Oncology, Hôpital Saint Louis, APHP, Paris, France. Electronic address: · Department of Urology, Institut Mutualiste Montsouris, Paris, France. Electronic address: · Medical Oncology Department, Hôpitaux Universitaires de Strasbourg, Strasbourg, France. Electronic address: · Department of Oncology, Antoine-Lacassagne Center, Nice, France. Electronic address: · Medical Oncology Department, CHIC Quimper, France. Electronic address: · Ramsay Générale de Santé, Hôpital Privé Clairval, Marseille, France. Electronic address: · Medical Oncology Department, Centre Hospitalier Lyon-Sud, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), CITOHL, F-69310, Pierre-Bénite, France. Electronic address: · Department of Urology, CHU Pellegrin, Bordeaux, France. Electronic address: · Oncologic surgery department 2, Institut Paoli-Calmettes, Marseille, France. Electronic address: · Department of Urology, Hôpital européen Georges-Pompidou (HEGP), Assistance Publique-Hôpitaux de Paris (APHP), Paris, France; Paris-Descartes University, Paris, France. Electronic address: · Department of Urology, Rennes University Hospital, Rennes, France. Electronic address: · Department of Urology, Clinique St Jean du Languedoc, Toulouse, France; Institut Universitaire du Cancer, Toulouse, France. Electronic address: · Department of Radiation therapy, Institut Bergonié, Bordeaux, France. Electronic address: · Pubmed 29458782
  • Department of Medical Cell BioPhysics, University of Twente, Enschede, The Netherlands. · Department of General, Visceral and Pediatric Surgery, University Hospital of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. · Department of Gynecology and Obstetrics, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. · Institute for Transplantation Diagnostics and Cell Therapeutics, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. · Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · DiSCOG, University of Padova, Padova, Italy. · Apheresis Unit, Blood Transfusion Service, University Hospital of Padova, Padova, Italy. · Department of Medicine, Université Paris-Saclay, Gustave Roussy, Villejuif, France. · INSERM U981 "Identification of Molecular Predictors and New Targets for Cancer Treatment", Gustave Roussy, Villejuif, France. · "Circulating Tumor Cells" Translational Platform, CNRS UMS3655 - INSERM US23 Ammica, Université Paris-Saclay, Gustave Roussy, Villejuif, France. · Cancer Biomarkers, Institute of Cancer Research, Sutton, UK. · Prostate Cancer Targeted Therapies Group, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Pubmed 30006930
2017
  • Department of Cancer Medicine, Gustave Roussy, Département de Médecine Oncologique, Université Paris-Saclay, Villejuif, France. · The Royal Marsden National Health Service Foundation Trust and The Institute of Cancer Research, Sutton, United Kingdom. · Medivation, Inc, San Francisco, California. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Pubmed 27648814
2016
  • Gustave Roussy, Université Paris-Saclay, Department of Medicine, F-94805, Villejuif, France. · INSERM, U981 "Identification of Molecular Predictors and New Targets for Cancer Treatment", F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Circulating Tumor Cells" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Hôpital d'Instruction des Armées du Val de Grâce, Department of Oncology, F-75005, Paris, France. · Gustave Roussy, Université Paris-Saclay, Department of Biopathology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, Department of Biostatistics and Epidemiology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Histo Cytopathology" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Pubmed 27391263
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 46 total) written by Yohann Loriot about Prostatic Neoplasms:

  • Management of non-metastatic castrate-resistant prostate cancer: A systematic review. 2018
  • [DNA damage repair: An emerging strategy in metastatic prostate cancer]. 2018
  • Loco-regional treatment for castration-resistant prostate cancer: Is there any rationale? A critical review from the AFU-GETUG. 2018
  • Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap). 2018
  • Health-related quality of life effects of enzalutamide in patients with metastatic castration-resistant prostate cancer: an in-depth post hoc analysis of EQ-5D data from the PREVAIL trial. 2017
  • Effect of Visceral Disease Site on Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide in the PREVAIL Trial. 2017
  • Phase I/II trial of cabazitaxel plus abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and abiraterone. 2017
  • Enzalutamide in castration-resistant prostate cancer patients with visceral disease in the liver and/or lung: Outcomes from the randomized controlled phase 3 AFFIRM trial. 2017
  • Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study. 2017
  • Long-term complete remission with Ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients. 2017
Show List of Full Article Records
Google Searches

Learn more about Yohann Loriot using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Institut Gustave Roussy
INSERM France
Universite Paris-Saclay
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Institut Gustave Roussy
2018
  • Gustave-Roussy, département de médecine, Inserm U981, 114, rue Édouard-Vaillant, 94805 Villejuif, France. · CHU de Besançon, oncologie, 25030 Besançon cedex, France. · CHU de Besançon, oncologie, 25030 Besançon cedex, France; Inserm, UMR1098, 25020 Besançon cedex, France; Université de Franche-Comté, UMR1098, SFR IBCT, 25020 Besançon, France. Electronic address: · Pubmed 30278883
  • Department of Medical Cell BioPhysics, University of Twente, Enschede, The Netherlands. · Department of General, Visceral and Pediatric Surgery, University Hospital of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. · Department of Gynecology and Obstetrics, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. · Institute for Transplantation Diagnostics and Cell Therapeutics, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. · Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · DiSCOG, University of Padova, Padova, Italy. · Apheresis Unit, Blood Transfusion Service, University Hospital of Padova, Padova, Italy. · Department of Medicine, Université Paris-Saclay, Gustave Roussy, Villejuif, France. · INSERM U981 "Identification of Molecular Predictors and New Targets for Cancer Treatment", Gustave Roussy, Villejuif, France. · "Circulating Tumor Cells" Translational Platform, CNRS UMS3655 - INSERM US23 Ammica, Université Paris-Saclay, Gustave Roussy, Villejuif, France. · Cancer Biomarkers, Institute of Cancer Research, Sutton, UK. · Prostate Cancer Targeted Therapies Group, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Pubmed 30006930
2017
  • Office of Health Economics, Southside, 7th Floor, 105 Victoria Street, London, SW1E 6QT, UK. · Office of Health Economics, Southside, 7th Floor, 105 Victoria Street, London, SW1E 6QT, UK. · European Association for the Study of the Liver-Chronic Liver Failure (EASL-CLIF) Consortium, C/Mallorca 183, 08036, Barcelona, Spain. · Astellas Pharma Global Development, J.H. Oortweg 62, 2333 BE, Leiden, The Netherlands. · Astellas Medical Affairs, Global Health Economic Outcomes Research (HEOR), 2000 Hillswood Dr, Chertsey, Surrey, KT16 0PS, UK. · OHSU Knight Cancer Institute, Oregon Health & Science University, 3303 SW Bond Ave., CH14R, Portland, OR, 97239, USA. · Institut de Recherche Clinique (IREC), Cliniques Universitaires Saint Luc, Av Hippocrate, 10 - 1200 Bruxelles - Belgique, Brussels, Belgium. · Institut Gustave Roussy, University of Paris Sud, 114, rue Edouard-Vaillant, 94805, Villejuif Cedex, France. · Quintiles, Siriusdreef 10 Beukenhorst Zuid 2132, WT, Hoofddorp, The Netherlands. · Medivation, Inc., 525 Market St, Fl 36, San Francisco, CA, 94105, USA. · Astellas Medical Affairs, Global HEOR, J.H. Oortweg 62, 2333 BE, Leiden, The Netherlands. · Pubmed 28645287
  • OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR. Electronic address: · Department of Medical Oncology, Guy's Hospital, London, UK. · Department of Cancer Medicine, Gustave Roussy, University of Paris-Sud, Villejuif, France. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Division of Clinical Studies, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Department of Urology, Cliniques universitaires Saint-Luc, Brussels, Belgium. · Department of Medical Oncology, Vall d'Hebron University Hospital, and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Medicine, University of Colorado School of Medicine, Aurora, CO. · Department of Medical Oncology, USC Norris Cancer Hospital, Keck Medical Center of USC, Los Angeles, CA. · Department of Biostatistics, Astellas Pharma Europe, BV, Leiden, Netherlands. · Department of Biostatistics, Medivation, Inc, San Francisco, CA. · Department of Clinical Development, Medivation, Inc, San Francisco, CA. · OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR. · Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA. · Pubmed 28344102
  • Department of Drug Development, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA. · Comprehensive Cancer Center Yale School of Medicine, New Haven. · Sanofi Genzyme, Cambridge, USA. · Pubmed 28039155
  • Department of Cancer Medicine, Gustave Roussy, Département de Médecine Oncologique, Université Paris-Saclay, Villejuif, France. · The Royal Marsden National Health Service Foundation Trust and The Institute of Cancer Research, Sutton, United Kingdom. · Medivation, Inc, San Francisco, California. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Pubmed 27648814
  • Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. Electronic address: · Duke Cancer Institute, Durham, NC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave-Roussy, Villejuif, France. · San Camillo and Forlanini Hospitals, Rome, Italy. · University of Washington, Seattle Cancer Care Alliance, Seattle, WA, USA. · Rigshospitalet, Copenhagen, Denmark. · UC Davis Cancer Center, Sacramento, CA, USA. · Asan Medical Center, Seoul, Korea. · Nippon Medical School, Tokyo, Japan. · Charité Universitätsmedizin, Berlin, Germany. · University of Montreal Hospital Center, Montreal, QC, Canada. · Skåne University Hospital, Malmö, Sweden. · Aarhus University Hospital, Aarhus, Denmark. · Radboud University Medical Center, Nijmegen, Netherlands. · Tampere University Hospital and University of Tampere, Tampere, Finland. · Medivation, San Francisco, CA, USA. · Astellas Pharma Europe, Leiden, The Netherlands. · Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27477525
  • Institut Gustave Roussy, University of Paris-Sud, Department of Cancer Medicine, 114 Rue Edouard Vaillant, 94800 Villejuif, France. · Institut Paoli-Calmettes, Department of Medical Oncology, 13009 Marseille, France. · Pubmed 28428880
  • Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA. · OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Department of Clinical Medicine, Rigshospitalet, Copenhagen, Denmark. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Cancer Medicine, Institut Gustave-Roussy, Villejuif, France. · Division of Clinical Studies, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Division of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Medical Affairs, Medivation, Inc., San Francisco, CA, USA. · Biostatistics, Medivation, Inc., San Francisco, CA, USA. · Medical Oncology, Astellas Pharma, Inc., Northbrook, IL, USA. · Biostatistics, Astellas Pharma, Inc., Northbrook, IL, USA. · Pubmed 28117385
  • Prostate Cancer Research, Montreal Cancer Institute/CRCHUM, Centre de Hospitalier de Université de Montréal, Montréal, QC, Canada. · Quintiles, Hoofddorp, The Netherlands. · Astellas Pharma, Leiden, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Medivation, San Francisco, CA, USA. · OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. · Cliniques universitaires Saint-Luc, Bruxelles, Belgium. · Astellas Medical Affairs, Global HEOR, Leiden, The Netherlands. · Pubmed 28045115
2016
  • Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Pubmed 27151554
  • Department of Urology, UC Davis Comprehensive Cancer Center, Sacramento, CA, USA. Electronic address: · Medical Oncology Division, University of Washington/Seattle Cancer Care Alliance, Seattle, WA, USA. · Department of Urology, Medical University of South Carolina, Charleston, SC, USA. · Division of Urologic Surgery, Washington University School of Medicine, St. Louis, MO, USA. · Department of Surgery, University of Montreal Health Center, Montreal, Canada. · Copenhagen Prostate Cancer Center, Rigshospitalet, University of Copenhagen, Denmark. · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Urology, Asan Medical Center, Seoul, South Korea. · Department of Urology, Nippon Medical School Hospital, Tokyo, Japan. · Division of Medical Oncology and Urology, Duke Cancer Institute, Durham, NC, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave-Roussy, Villejuif, France. · Drug Development Unit, Institute of Cancer Research, Royal Marsden Hospital, London, UK. · Department of Early Clinical Development, Medivation, Inc., San Francisco, CA, USA. · Department of Medical Affairs, Medivation, Inc., San Francisco, CA, USA. · Department of Biostatistics, Medivation, Inc., San Francisco, CA, USA. · Astellas Pharma, Inc., Northbrook, IL, USA. · Department of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27006332
  • Gustave Roussy, Université Paris-Saclay, Department of Medicine, F-94805, Villejuif, France. · INSERM, U981 "Identification of Molecular Predictors and New Targets for Cancer Treatment", F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Circulating Tumor Cells" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Hôpital d'Instruction des Armées du Val de Grâce, Department of Oncology, F-75005, Paris, France. · Gustave Roussy, Université Paris-Saclay, Department of Biopathology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, Department of Biostatistics and Epidemiology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Histo Cytopathology" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Pubmed 27391263
  • The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France INSERM U981, Villejuif, France. · The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada · Pubmed 27198502
  • INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Bergonie Cancer Institute, Bordeaux, France. · INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Biopathology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. · Pubmed 26923772
  • Department of Medical Oncology, Institut Bergonié, Bordeaux. · Department of Medical Oncology, Clinique Francheville, Périgueux. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif. · Department of Radiotherapy, Institut Bergonié, Bordeaux, France. · Department of Medical Oncology, Institut Bergonié, Bordeaux · Pubmed 26445811
2015
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Pubmed 25922192
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Drug Development Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Department of Urology, Guys and St Thomas' Hospital, London, UK. · Department of Medicine, Division of Medical Oncology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Early Clinical Development, Medivation, San Francisco, CA, USA. · Health Economics and Outcomes Research, Astellas Pharma Europe, Leiden, Netherlands. · Department of Medical Affairs, Medivation, San Francisco, CA, USA. · Astellas Pharma Global Development, Northbrook, IL, USA. · Consulting, Quintiles, Hoofddorp, Netherlands. · Consulting, Quintiles, Barcelona, Spain; Department of Public Health, University of Barcelona, Barcelona, Spain. · Division of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 25888263
  • University of Montreal Hospital Centre, Montreal, QC, Canada. Electronic address: · Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Gustave Roussy, Cancer Campus Grand Paris, University of Paris Sud, Villejuif, France. · Medivation, Inc., San Francisco, CA, USA. · Astellas Global Medical Affairs, Inc., Northbrook, IL, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 25171902
  • Department of Ambulatory Care, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. Electronic address: · Department of Biostatistics and Epidemiology, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Gustave-Roussy Cancer Campus, Villejuif, University of Paris Sud, France. · Department of Ambulatory Care, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Pubmed 26278649
  • Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Institut Jean Godinot, Reims, France. · Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Pubmed 26208462
  • Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Urology, University Hospital of Pointe-à-Pitre, France. · Department of Urology, Kremlin-Bicêtre Hospital, University of Paris-Sud, Kremlin-Bicêtre, France. · Department of Urology, Saint-Joseph Hospital, Paris, France. · Department of Radiotherapy, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Forestry and Management of the Environment and Natural Resources, School of Agricultural Sciences and Forestry, Democritus University, Alexandroupoli, Greece. · Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Pubmed 25746940
  • Department of Medicine, University of Washington, Seattle, WA, USA. Electronic address: · Janssen Research and Development, Los Angeles, CA, USA. · Janssen Research and Development, Menlo Park, CA, USA. · Janssen Research and Development, Raritan, NJ, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Institut Gustave Roussy, Villejuif, France. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, UK. · Pubmed 25018037
  • Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, Val de Grâce Hospital, Paris, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, CHU de Bordeaux, Bordeaux, France. · Pitié-Salpetrière Hospital, Paris, France. · Institut de Cancérologie de la Loire, Saint-Etienne, France. · Biostatistics and Epidemiology unit, Institut Gustave Roussy, Cancer Campus, Grand Paris, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Pubmed 24837187
2014
  • Department of Cancer Medicine, Institut Gustave Roussy and University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Institut Gustave Roussy and University of Paris Sud, Villejuif, France; Drug Development Department, SITEP, Institut Gustave Roussy, Villejuif, France. Electronic address: · Pubmed 24735730
  • Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris Sud, Villejuif, France. · Pubmed 24075577
  • Institut Gustave-Roussy, DITEP, Département d'innovations thérapeutiques et essais précoces, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. · Institut Gustave-Roussy, Département de médecine oncologique, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France. · Service d'oncologie et hématologie, 4, rue Louis-Pasteur, 28630 Chartres Le Coudray, France. · Pubmed 24793632
  • Institute Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Villejuif, France, · Pubmed 24771350
  • Department of Cancer Medicine, Gustave Roussy, Villejuif, France. · Institut Jean-Godinot, Reims, France. · Pubmed 25311767
2013
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Sud, INSERM 981, Villejuif, France. · Pubmed 23576708
2012
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 22267211
2010
  • Department of Medicine, Institut Gustave Roussy, Villejuif, France. · Pubmed 20483588
2015
  • a Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, 114 rue Edouard Vaillant, 94800 Villejuif, France. · Pubmed 26313416
2012
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif 94800, France. · Pubmed 22987974
2010
  • Department of Medicine, Institut Gustave Roussy, University of Paris XI, Villejuif, France. · Pubmed 20181574
  • Institut Gustave-Roussy, Département de Médecine, 39 Rue Camille-Desmoulins, 94800 Villejuif, France. · Pubmed 20022854
2009
  • Department of Medicine, Institut Gustave Roussy, Villejuif, France. · Pubmed 19364971
INSERM France
2018
  • Gustave-Roussy, département de médecine, Inserm U981, 114, rue Édouard-Vaillant, 94805 Villejuif, France. · CHU de Besançon, oncologie, 25030 Besançon cedex, France. · CHU de Besançon, oncologie, 25030 Besançon cedex, France; Inserm, UMR1098, 25020 Besançon cedex, France; Université de Franche-Comté, UMR1098, SFR IBCT, 25020 Besançon, France. Electronic address: · Pubmed 30278883
  • Department of Medical Cell BioPhysics, University of Twente, Enschede, The Netherlands. · Department of General, Visceral and Pediatric Surgery, University Hospital of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. · Department of Gynecology and Obstetrics, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. · Institute for Transplantation Diagnostics and Cell Therapeutics, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. · Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · DiSCOG, University of Padova, Padova, Italy. · Apheresis Unit, Blood Transfusion Service, University Hospital of Padova, Padova, Italy. · Department of Medicine, Université Paris-Saclay, Gustave Roussy, Villejuif, France. · INSERM U981 "Identification of Molecular Predictors and New Targets for Cancer Treatment", Gustave Roussy, Villejuif, France. · "Circulating Tumor Cells" Translational Platform, CNRS UMS3655 - INSERM US23 Ammica, Université Paris-Saclay, Gustave Roussy, Villejuif, France. · Cancer Biomarkers, Institute of Cancer Research, Sutton, UK. · Prostate Cancer Targeted Therapies Group, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Pubmed 30006930
2016
  • Gustave Roussy, Université Paris-Saclay, Department of Medicine, F-94805, Villejuif, France. · INSERM, U981 "Identification of Molecular Predictors and New Targets for Cancer Treatment", F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Circulating Tumor Cells" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Hôpital d'Instruction des Armées du Val de Grâce, Department of Oncology, F-75005, Paris, France. · Gustave Roussy, Université Paris-Saclay, Department of Biopathology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, Department of Biostatistics and Epidemiology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Histo Cytopathology" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Pubmed 27391263
  • The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France INSERM U981, Villejuif, France. · The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada · Pubmed 27198502
2015
  • Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, Val de Grâce Hospital, Paris, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, CHU de Bordeaux, Bordeaux, France. · Pitié-Salpetrière Hospital, Paris, France. · Institut de Cancérologie de la Loire, Saint-Etienne, France. · Biostatistics and Epidemiology unit, Institut Gustave Roussy, Cancer Campus, Grand Paris, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Pubmed 24837187
2013
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Sud, INSERM 981, Villejuif, France. · Pubmed 23576708
Universite Paris-Saclay
2018
  • Medical Oncology Department, Gustave Roussy, Université Paris-Saclay, Paris, France. Electronic address: · Radiation Therapy Department, Institut de Cancérologie de L'Ouest René Gauducheau, Nantes St Herblain and Centre de Recherche en Cancérologie et Immunologie, Nantes-Angers, France. · Department of Urology, CHU Rangueil, Toulouse, France. · Medical Oncology Department, CHIC Quimper, France; CHRU Brest, Institut de Cancérologie et Hématologie, Brest, France. · Groupe Urologie Bordeaux Saint Gatien- Clinique TIVOLI-DUCOS, GROUPE SAINT GATIEN, Bordeaux, France. · Department of Radiation Therapy, Institut Bergonié, Bordeaux, France. · Medical Oncology and Hematology Department, Hôpitaux Universitaires de Strasbourg, Strasbourg, France. · Service de Chirurgie Oncologique 2, Institut Paoli-Calmettes, Marseille, France. · Medical Oncology Department, Centre Hospitalier Lyon-Sud, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), CITOHL, F-69310 Pierre-Bénite, France. · Department of Urology, Rennes University Hospital, Rennes, France. · Ramsay Générale de Santé, Hôpital Privé Clairval, Marseille, France. · Department of Urology, Clinique La Croix du Sud-St Jean Languedoc, Toulouse, France, Institut Universitaire du Cancer, Toulouse, France. · Department of Urology, Hôpital européen Georges-Pompidou (HEGP), Assistance Publique-Hôpitaux de Paris (APHP), Paris, France; Paris-Descartes University, Paris, France. · Department of Oncology, Antoine-Lacassagne Center, Nice, France. · Pubmed 30300771
  • Department of Urology, CHU Rangueil, Toulouse, France. Electronic address: · Medical oncology department, Gustave Roussy, Université Paris-Saclay, Paris, France. Electronic address: · Department of Radiation Oncology, Hôpital Saint Louis, APHP, Paris, France. Electronic address: · Department of Urology, Institut Mutualiste Montsouris, Paris, France. Electronic address: · Medical Oncology Department, Hôpitaux Universitaires de Strasbourg, Strasbourg, France. Electronic address: · Department of Oncology, Antoine-Lacassagne Center, Nice, France. Electronic address: · Medical Oncology Department, CHIC Quimper, France. Electronic address: · Ramsay Générale de Santé, Hôpital Privé Clairval, Marseille, France. Electronic address: · Medical Oncology Department, Centre Hospitalier Lyon-Sud, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), CITOHL, F-69310, Pierre-Bénite, France. Electronic address: · Department of Urology, CHU Pellegrin, Bordeaux, France. Electronic address: · Oncologic surgery department 2, Institut Paoli-Calmettes, Marseille, France. Electronic address: · Department of Urology, Hôpital européen Georges-Pompidou (HEGP), Assistance Publique-Hôpitaux de Paris (APHP), Paris, France; Paris-Descartes University, Paris, France. Electronic address: · Department of Urology, Rennes University Hospital, Rennes, France. Electronic address: · Department of Urology, Clinique St Jean du Languedoc, Toulouse, France; Institut Universitaire du Cancer, Toulouse, France. Electronic address: · Department of Radiation therapy, Institut Bergonié, Bordeaux, France. Electronic address: · Pubmed 29458782
  • Department of Medical Cell BioPhysics, University of Twente, Enschede, The Netherlands. · Department of General, Visceral and Pediatric Surgery, University Hospital of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. · Department of Gynecology and Obstetrics, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. · Institute for Transplantation Diagnostics and Cell Therapeutics, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. · Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · DiSCOG, University of Padova, Padova, Italy. · Apheresis Unit, Blood Transfusion Service, University Hospital of Padova, Padova, Italy. · Department of Medicine, Université Paris-Saclay, Gustave Roussy, Villejuif, France. · INSERM U981 "Identification of Molecular Predictors and New Targets for Cancer Treatment", Gustave Roussy, Villejuif, France. · "Circulating Tumor Cells" Translational Platform, CNRS UMS3655 - INSERM US23 Ammica, Université Paris-Saclay, Gustave Roussy, Villejuif, France. · Cancer Biomarkers, Institute of Cancer Research, Sutton, UK. · Prostate Cancer Targeted Therapies Group, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Pubmed 30006930
2017
  • Department of Cancer Medicine, Gustave Roussy, Département de Médecine Oncologique, Université Paris-Saclay, Villejuif, France. · The Royal Marsden National Health Service Foundation Trust and The Institute of Cancer Research, Sutton, United Kingdom. · Medivation, Inc, San Francisco, California. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Pubmed 27648814
2016
  • Gustave Roussy, Université Paris-Saclay, Department of Medicine, F-94805, Villejuif, France. · INSERM, U981 "Identification of Molecular Predictors and New Targets for Cancer Treatment", F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Circulating Tumor Cells" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Hôpital d'Instruction des Armées du Val de Grâce, Department of Oncology, F-75005, Paris, France. · Gustave Roussy, Université Paris-Saclay, Department of Biopathology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, Department of Biostatistics and Epidemiology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Histo Cytopathology" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Pubmed 27391263
Universite Paris 11 Sud
2017
  • Office of Health Economics, Southside, 7th Floor, 105 Victoria Street, London, SW1E 6QT, UK. · Office of Health Economics, Southside, 7th Floor, 105 Victoria Street, London, SW1E 6QT, UK. · European Association for the Study of the Liver-Chronic Liver Failure (EASL-CLIF) Consortium, C/Mallorca 183, 08036, Barcelona, Spain. · Astellas Pharma Global Development, J.H. Oortweg 62, 2333 BE, Leiden, The Netherlands. · Astellas Medical Affairs, Global Health Economic Outcomes Research (HEOR), 2000 Hillswood Dr, Chertsey, Surrey, KT16 0PS, UK. · OHSU Knight Cancer Institute, Oregon Health & Science University, 3303 SW Bond Ave., CH14R, Portland, OR, 97239, USA. · Institut de Recherche Clinique (IREC), Cliniques Universitaires Saint Luc, Av Hippocrate, 10 - 1200 Bruxelles - Belgique, Brussels, Belgium. · Institut Gustave Roussy, University of Paris Sud, 114, rue Edouard-Vaillant, 94805, Villejuif Cedex, France. · Quintiles, Siriusdreef 10 Beukenhorst Zuid 2132, WT, Hoofddorp, The Netherlands. · Medivation, Inc., 525 Market St, Fl 36, San Francisco, CA, 94105, USA. · Astellas Medical Affairs, Global HEOR, J.H. Oortweg 62, 2333 BE, Leiden, The Netherlands. · Pubmed 28645287
  • OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR. Electronic address: · Department of Medical Oncology, Guy's Hospital, London, UK. · Department of Cancer Medicine, Gustave Roussy, University of Paris-Sud, Villejuif, France. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Division of Clinical Studies, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Department of Urology, Cliniques universitaires Saint-Luc, Brussels, Belgium. · Department of Medical Oncology, Vall d'Hebron University Hospital, and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Medicine, University of Colorado School of Medicine, Aurora, CO. · Department of Medical Oncology, USC Norris Cancer Hospital, Keck Medical Center of USC, Los Angeles, CA. · Department of Biostatistics, Astellas Pharma Europe, BV, Leiden, Netherlands. · Department of Biostatistics, Medivation, Inc, San Francisco, CA. · Department of Clinical Development, Medivation, Inc, San Francisco, CA. · OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR. · Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA. · Pubmed 28344102
  • Department of Drug Development, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA. · Comprehensive Cancer Center Yale School of Medicine, New Haven. · Sanofi Genzyme, Cambridge, USA. · Pubmed 28039155
  • Institut Gustave Roussy, University of Paris-Sud, Department of Cancer Medicine, 114 Rue Edouard Vaillant, 94800 Villejuif, France. · Institut Paoli-Calmettes, Department of Medical Oncology, 13009 Marseille, France. · Pubmed 28428880
  • Prostate Cancer Research, Montreal Cancer Institute/CRCHUM, Centre de Hospitalier de Université de Montréal, Montréal, QC, Canada. · Quintiles, Hoofddorp, The Netherlands. · Astellas Pharma, Leiden, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Medivation, San Francisco, CA, USA. · OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. · Cliniques universitaires Saint-Luc, Bruxelles, Belgium. · Astellas Medical Affairs, Global HEOR, Leiden, The Netherlands. · Pubmed 28045115
2016
  • Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Pubmed 27151554
  • The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France INSERM U981, Villejuif, France. · The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada · Pubmed 27198502
  • Department of Medical Oncology, Institut Bergonié, Bordeaux. · Department of Medical Oncology, Clinique Francheville, Périgueux. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif. · Department of Radiotherapy, Institut Bergonié, Bordeaux, France. · Department of Medical Oncology, Institut Bergonié, Bordeaux · Pubmed 26445811
2015
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Pubmed 25922192
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Drug Development Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Department of Urology, Guys and St Thomas' Hospital, London, UK. · Department of Medicine, Division of Medical Oncology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Early Clinical Development, Medivation, San Francisco, CA, USA. · Health Economics and Outcomes Research, Astellas Pharma Europe, Leiden, Netherlands. · Department of Medical Affairs, Medivation, San Francisco, CA, USA. · Astellas Pharma Global Development, Northbrook, IL, USA. · Consulting, Quintiles, Hoofddorp, Netherlands. · Consulting, Quintiles, Barcelona, Spain; Department of Public Health, University of Barcelona, Barcelona, Spain. · Division of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 25888263
  • University of Montreal Hospital Centre, Montreal, QC, Canada. Electronic address: · Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Gustave Roussy, Cancer Campus Grand Paris, University of Paris Sud, Villejuif, France. · Medivation, Inc., San Francisco, CA, USA. · Astellas Global Medical Affairs, Inc., Northbrook, IL, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 25171902
  • Department of Ambulatory Care, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. Electronic address: · Department of Biostatistics and Epidemiology, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Gustave-Roussy Cancer Campus, Villejuif, University of Paris Sud, France. · Department of Ambulatory Care, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Pubmed 26278649
  • Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Institut Jean Godinot, Reims, France. · Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Pubmed 26208462
  • Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Urology, University Hospital of Pointe-à-Pitre, France. · Department of Urology, Kremlin-Bicêtre Hospital, University of Paris-Sud, Kremlin-Bicêtre, France. · Department of Urology, Saint-Joseph Hospital, Paris, France. · Department of Radiotherapy, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Forestry and Management of the Environment and Natural Resources, School of Agricultural Sciences and Forestry, Democritus University, Alexandroupoli, Greece. · Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Pubmed 25746940
  • Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, Val de Grâce Hospital, Paris, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, CHU de Bordeaux, Bordeaux, France. · Pitié-Salpetrière Hospital, Paris, France. · Institut de Cancérologie de la Loire, Saint-Etienne, France. · Biostatistics and Epidemiology unit, Institut Gustave Roussy, Cancer Campus, Grand Paris, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Pubmed 24837187
2014
  • Department of Cancer Medicine, Institut Gustave Roussy and University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Institut Gustave Roussy and University of Paris Sud, Villejuif, France; Drug Development Department, SITEP, Institut Gustave Roussy, Villejuif, France. Electronic address: · Pubmed 24735730
  • Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris Sud, Villejuif, France. · Pubmed 24075577
  • Institute Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Villejuif, France, · Pubmed 24771350
2013
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Sud, INSERM 981, Villejuif, France. · Pubmed 23576708
2012
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 22267211
2015
  • a Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, 114 rue Edouard Vaillant, 94800 Villejuif, France. · Pubmed 26313416
2012
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif 94800, France. · Pubmed 22987974
2010
  • Department of Medicine, Institut Gustave Roussy, University of Paris XI, Villejuif, France. · Pubmed 20181574
University of British Columbia
2015
  • The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Japan. · The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Antisense Drug Discovery, Isis Pharmaceuticals Inc., Carlsbad, California. · The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 25634993
2012
  • Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 23084528
5 Other Locations Show
Yearly article counts 0486116231320
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.